Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for Diabetic Neuropathic Pain
NCT04137328Unknown
- Sponsor
- Fudan University
- Start
- Nov 2019
- Primary completion
- Nov 2022
- Modality
- Peptides
01
Overview
Randomised, open-label trial of liraglutide in diabetic neuropathy (2 arms), sponsored by Fudan University. Primary endpoint: Numerical Pain Scale at 3 months. Status: unknown.
02
Drugs
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT04137328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04137328.